Dyne Therapeutics, Inc.
DYN
$12.40
$0.161.31%
| Weiss Ratings | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.81 | |||
| Price History | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.08% | |||
| 30-Day Total Return | -9.42% | |||
| 60-Day Total Return | -57.97% | |||
| 90-Day Total Return | -60.13% | |||
| Year to Date Total Return | -51.30% | |||
| 1-Year Total Return | -53.10% | |||
| 2-Year Total Return | -15.99% | |||
| 3-Year Total Return | 52.33% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -74.20% | |||
| 52-Week Low % Change | 5.34% | |||
| Price | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $47.45 | |||
| 52-Week Low Price | $11.62 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Aug 20, 2024 | |||
| Valuation | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.38B | |||
| Enterprise Value | 766.33M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.35 | |||
| Earnings Per Share Growth | -14.86% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.99 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $12.40 | |||
| Enterprise Value/EBITDA (TTM) | -2.24 | |||
| Enterprise Value/EBIT | -2.23 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 101.98M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 786 8230 | |||
| Address | 1560 Trapelo Road Waltham, MA 02451 | |||
| Website | www.dyne-tx.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -50.20% | |||
| Return on Equity | -- | |||
| Income Statement | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -342.21M | |||
| EBIT (TTM) | -343.89M | |||
| Net Income (TTM) | -317.42M | |||
| Net Income Avl. to Common (TTM) | -317.42M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -34.37% | |||
| EPS Diluted (TTM) | -3.35 | |||
| EPS Diluted Growth (Q YOY) | 19.11% | |||
| Balance Sheet | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 642.27M | |||
| Cash Per Share (Q) | $6.30 | |||
| Total Current Assets (Q) | 659.28M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 629.84M | |||
| Current Ratio (Q) | 15.601 | |||
| Book Value Per Share (Q) | $6.16 | |||
| Total Assets (Q) | 691.23M | |||
| Total Current Liabilities (Q) | 42.26M | |||
| Total Debt (Q) | 23.99M | |||
| Total Liabilities (Q) | 61.40M | |||
| Total Common Equity (Q) | 629.84M | |||
| Cash Flow | DYN - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -204.08M | |||
| Cash from Financing (TTM) | 809.90M | |||
| Net Change in Cash (TTM) | 313.45M | |||
| Levered Free Cash Flow (TTM) | -189.47M | |||
| Cash from Operations (TTM) | -292.37M | |||
